Assessment of the relationship between serum soluble Klotho and carotid intima–media thickness and left ventricular dysfunction in hemodialysis patients

Assessment of the relationship between serum soluble Klotho and carotid intima–media thickness and left ventricular dysfunction in hemodialysis patients

Background: The aim of our study was to assess the relationship between soluble Klotho (s-Klotho) and carotid intima–media thickness (CIMT) and left ventricular (LV) dysfunction in hemodialysis (HD) patients. Methods: This is a cross-sectional study conducted on 88 patients with end-stage renal dise...

Full description

Bibliographic Details
Main Authors:	Emad Abdallah, Osama Mosbah, Ghada Khalifa, Amna Metwaly, Omnia El-Bendary
Format:	Article
Language:	English
Published:	The Korean Society of Nephrology 2016-03-01
Series:	Kidney Research and Clinical Practice
Subjects:	Cardiovascular diseases End-stage renal disease Fibroblast growth factor-23 Soluble Klotho
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211913215300589

Similar Items

Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients
by: Eleni Manou, et al.
Published: (2020-10-01)

Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration
by: L Yu Milovanova, et al.
Published: (2018-06-01)

Testing bone cell models responsive to a soluble form of klotho
by: Bonfitto, Anna
Published: (2017)

Serum and urinary soluble alpha klotho levels in patients with Chronic kidney disease
by: Khalid Jamal Al-Jewari, et al.
Published: (2021-04-01)

Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis
by: Ai-hua Zhang, et al.
Published: (2019-05-01)

Effect of High Intensity Interval Training on the Level of Atrial Fibrillation, Fibroblast Growth Factor 23 and Klotho Protein in Male Rats with Renal Failure
by: Sina Rokhsati, et al.
Published: (2020-07-01)

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
by: Javier Donate-Correa, et al.
Published: (2019-04-01)

Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
by: Shubei Zheng, et al.
Published: (2018-04-01)

Protein Klotho and FGF23 fibroblasts growth factor as markers of chronic renal disease
by: A.A. Melnik
Published: (2017-08-01)

Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease
by: L Yu Milovanova, et al.
Published: (2015-06-01)

A Decreased Level of Soluble Klotho Can Predict Cardiovascular Death in No or Mild Abdominal Aortic Calcification Hemodialysis Patients
by: Hong Cai, et al.
Published: (2021-05-01)

FGF23 Actions on Target Tissues—With and Without Klotho
by: Beatrice Richter, et al.
Published: (2018-05-01)

Role of sclerostin, fibroblast growth factor-23, and Klotho in hemodialysis patients
by: Azza A I. Elmenyawi, et al.
Published: (2019-01-01)

Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker
by: Przemyslaw J. Kotyla, et al.
Published: (2018-12-01)

A Novel Heterozygous Deletion Variant in <i>KLOTHO</i> Gene Leading to Haploinsufficiency and Impairment of Fibroblast Growth Factor 23 Signaling Pathway
by: Ernesto Martín-Núñez, et al.
Published: (2019-04-01)

New Insights into the Mechanism of Action of Soluble Klotho
by: George D. Dalton, et al.
Published: (2017-11-01)

Correlation of serum soluble Klotho with fibroblast growth factor 23 levels in chronic kidney disease patients; a single centre study
by: Yuvaraj Anand, et al.
Published: (2020-01-01)

The Organ Handling of Soluble Klotho in Humans
by: Daniela Picciotto, et al.
Published: (2019-08-01)

Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis
by: Shubei ZHENG, et al.
Published: (2018-04-01)

Low serum Klotho level as a predictor of calcification of the heart and blood vessels in patients with CKD stages 2–5D
by: Ludmila Yu. Milovanova, et al.
Published: (2020-07-01)

Bone mineral disorder in chronic kidney disease: Klotho and FGF23; cardiovascular implications
by: Laura Salanova Villanueva, et al.
Published: (2016-07-01)

Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD
by: Rathika Krishnasamy, et al.
Published: (2017-09-01)

Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
by: TOMŞA Anamaria Magdalena, et al.
Published: (2020-09-01)

Soluble Alpha-Klotho Alleviates Cardiac Fibrosis without Altering Cardiomyocytes Renewal
by: Wei-Yu Chen
Published: (2020-03-01)

The association between soluble klotho and cardiovascular parameters in chronic kidney disease: results from the KNOW-CKD study
by: Hyo Jin Kim, et al.
Published: (2018-03-01)

Editorial: Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
by: Reinhold G. Erben
Published: (2019-01-01)

Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis
by: Evangelos Memmos, et al.
Published: (2019-06-01)

Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes
by: Eda Dokumacioglu, et al.
Published: (2019-01-01)

Serum klotho: a potential predictor of cerebrovascular disease in hemodialysis patients
by: Honglan Wei, et al.
Published: (2019-02-01)

The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease
by: Melahat Coban, et al.
Published: (2018-07-01)

Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis
by: Ling Yu, et al.
Published: (2018-07-01)

Serum Klotho in Living Kidney Donors and Kidney Transplant Recipients: A Meta-Analysis
by: Charat Thongprayoon, et al.
Published: (2020-06-01)

Bone mineral density, carotid artery intima-media thickness, and Klotho gene polymorphism in postmenopausal women
by: Muntean Laura, et al.
Published: (2014-04-01)

FGF-23, Klotho and Vitamin D Levels in Scleroderma
by: Ravan AHMADI, et al.
Published: (2017-04-01)

Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
by: Ana Paula Silva, et al.
Published: (2019-03-01)

The Protective Role of Klotho in CKD-Associated Cardiovascular Disease
by: Xianjin Bi, et al.
Published: (2020-08-01)

Intact Fibroblast Growth Factor 23 and Peripheral Vascular Complications in Patients on Hemodialysis
by: Melahat, et al.
Published: (2020-03-01)

Endocrine and Paracrine Role of FGF23 and Klotho in Health and Disease
Published: (2019)

The Clinical Value of Klotho and FGF23 in Cardiac Valve Calcification Among Patients with Chronic Kidney Disease
by: Chen Y, et al.
Published: (2021-03-01)

Protective Effects of Moderate Ca Supplementation against Cd-Induced Bone Damage under Different Population-Relevant Doses in Young Female Rats
by: Xiao Huang, et al.
Published: (2019-04-01)